‫ܮ‬ ‫‬ ݃ ‫ܦ‬ is one of the important parameters used in Lipinski's rule to assess the druggability of a molecule in pharmaceutical formulations. It represents the logarithm ‫݈݃(‬ ଵ ) of the distribution coefficient ‫)ܦ(‬ of a molecule. The distribution coefficient is defined as the ratio of the concentration of the sum of ionized and unionized species of a molecule distributed between a hydrophobic organic phase and an aqueous buffer phase. Since the ‫‬ ‫ܪ‬ affects the ionic state of a molecule, ݈ ‫‬ ݃ ‫ܦ‬ value (which is dependent on the concentrations of the ionized species) also becomes dependent on ‫‬ ‫ܪ‬ . In this work, the conventional algebraic method is compared with a more generalized 'dynamic' approach to model the distribution coefficient of amphoteric, diamino-monoprotic molecule and monoprotic acid in the presence of salt or co-solvent. Recently reported experimental ݈ ‫‬ ݃ ‫ܦ‬ data of amphoteric molecules such as nalidixic acid, mebendazole, benazepril and telmisartan, were analyzed using both these approaches to show their equivalence.
Theory
The algebraic and the dynamic expressions for amphoteric, monoprotic acid in the presence of salt (KCl), co-solvent (DMSO) are explicitly derived in this section.
Additional cases such as monoprotic acid (SI.1), diprotic acid (SI.2), monoalkaline (SI.3), diamino-monoprotic amphoteric molecules (SI. 7) are detailed in the supplementary information. At the outset, kinetic mechanism that best represent the distribution of the molecule between an aqueous buffer and octanol layer will be outlined. Based on the kinetic mechanism, the algebraic and the dynamic models will be derived. between an aqueous buffer and an organic hydrophobic solvent (octanol) ( Figure 1A ) [5, 6, 11] . In the aqueous phase, the amino acid, is excluded from the kinetic mechanism.
Dynamic method for simple amino acids:
Based on the kinetic mechanism (Eqns. Figure 1B , the parameters such as , were set to 1.0,0,0,0,0,0, 0,0, respectively and the
‫‬ ‫ܪ‬
, was varied linearly between 1 and 10.
Monoprotic acid with salt (KCl)

Kinetic model for monoprotic acid with salt (KCl)
Consider the distribution of a weak mono-protic acid ‫)ܣܪ(‬ between an aqueous solvent and an organic hydrophobic solvent (octanol) in the presence of a potassium chloride (KCl) ( Figure 2A ) [3, 5, 12, 13] .
In aqueous phase, the weak acid, 
The ionized species
, would require its negative charge be neutralized before partitioned into octanol layer through the prevalent cation,
‫ܭ‬ ା
, coming from the dissociation of KCl. The forward and reverse kinetic rates of the partition of
, respectively, as given below (Eqn. 24),
Additionally, as seen with the monoprotic acid (SI.1), it is also possible for a fraction of the ionized species 
Finally, all the four species
‫ܪ‬ ‫ܣ‬
,
, partitioned into the octanol layer undergo a dynamic equilibrium whose forward and reverse kinetic rates are given as
, respectively (Eqn. 27).
Algebraic method for monoprotic acid with KCl:
Applying 
By substituting the analytical expressions of
Eqn. 28, we obtain,
To simulate the ݈ ‫‬ ݃ ଵ ‫ܦ‬ profile in Figure 2B , the parameters such as to that of a model of simple monoprotic acid.
Dynamic method for monoprotic acid with KCl:
Based on the kinetic mechanism (Eqns. 20 -27), the rate equation can be written for the ten species,
By numerically integrating the above set of coupled differential equations, Eqns 30 -39, we obtain the concentration of ten species, Figure 2B , the parameters such as
were set to 
3. Monoprotic acid in the presence of co-solvent
Kinetic model for monoprotic acid in the presence of co-solvent
Consider the distribution of a weak mono-protic acid ‫)ܣܪ(‬ between an aqueous solvent and an organic hydrophobic solvent (octanol) in the presence of co-solvent (ܵ) such as DMSO ( Figure 3A ) [3, 4] .
In aqueous phase, the weak acid, . The equilibrium between these two states can be written as (Eqn. 40),
The distribution of a co-solvent between an aqueous buffer and octanol is given by (Eq.
41)
are the forward and reverse kinetic rates for the partition of the co-solvent 
; are the forward and reverse kinetic rates for the co-solvation of 
, are the forward and reverse kinetic rates for the co-solvation of 
Algebraic method for monoprotic acid in the presence of co-solvent:
Dynamic method for monoprotic acid in the presence of co-solvent:
The differential equations for the rate of change of different species can be framed based on the kinetic mechanism given by (Eqns. 40 -47 Figure 3B&D , the parameters such as
, were set to , was varied linearly between 1 and 12.
Results:
In a recent ݈ ‫‬ ݃ ଵ ‫ܦ‬ comparison study, several amphoteric molecules of pharmaceutical interest were analysed using both shake flask (octanol-buffer) and potentiometric method [10] . Among those molecules, the experimental data of nalidixic acid, mebendazole, benazepril, telmisartan were considered for our current analysis [10] . Though, nalidixic acid and mebendazole are amphoteric in nature, the ݈ ‫‬ ݃ ଵ ‫ܦ‬ profile for both these molecules could be well represented through a monoprotic and monalkaline model, respectively ( Figure 4A & B) . Despite the fact that, benazepril is a complex amphoteric molecule with two amino group and one carboxylic acid group, its
data could be explained through a simple amino acid model (monoprotic-monalkaline) ( Figure 4C ). On the other-hand, telmisartan, required a complex monoprotic-dialkaline model to fit its experimental data ( Figure 4D ). The optimized Thus, we observe that the effect of co-solvent on
profile is non-linear, and is depended on the stoichiometry ratios that determine the degree of co-solvation of different monoprotic species.
Discussion:
The complex
profile of telmisartan could be explained only through di-alkalinemonoprotic model. In this model eight different species were consider to exist in aqueous phase and an additional eight species were considered to be partitioned into the octanol phase. Considering only the eight species that are present in the aqueous phase, there are multiple ways a kinetic mechansim can be proposed by interconnecting these eight species among itself through a network of equilibrium reactions. For example, if we consider each species as a 'node' and the interconnecting equilibrium reactions as bidirectional 'edges', then the graph theory suggest a maximum of
, edges or equilibrium reactions to exist among ܰ = 8, species [14] . Under such a circumstance, developing an algebraic model based on the kinetic mechanism can be considerably simplified by choosing only seven unique equilibriums that inter connect any of these eight species. Further, by including the law of conservation of mass of the di-alkaline-monoprotic molecule as a constraint and an additional eight equations derived from the partitioning of the eight species between aqueous and octanol layer, we obtain 16 algebraic equations to solve for the concentrations of 16 species at equilibrium. On the other-hand, in the dynamic approach, the nature of the rate equation for the sixteen species will depend primarily on the network of equilibriums that is assumed to exist among the species. Even though the concentrations of the 16 species will vary during the pre-steady state condition, at equilibrium or steady state, the concentrations remains invariably the same, for equivalent kinetic mechanisms. obtained through algebraic and dynamic methods were comparable and equivalent to a degree of two decimal points for most of the data points ( Table 2 ). The minor discrepancies seen in the accuracy of dynamic method compared to algebraic method is caused by errors in numerical integration when solving ordinary differential equations , increases with increase in co-solvent concentration [15] .
Supporting Information
Supporting Information contains explicit derivation of log 10 Tables: Table 1 benazepril and (D) telmisartan using monoprotic, monoalkaline, simple amphoteric and diamino-monoprotic amphoteric models, respectively. The data were fitted using an inhouse written matlab code [16] . 
